Alexo Therapeutics was formed in 2015 as an independent, private biotech company, located in South San Francisco. The company is focused on developing new protein-based therapeutics to treat cancer.
Company (Alive / Active)
951 Gateway Blvd.
South San Francisco, 94080
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Antibodies against signal-regulatory protein alpha and methods of use||Sep 20, 2017||Application|
|Constructs having a sirp-alpha domain or variant thereof||Aug 05, 2016||Application|
|Sirp-alpha variant constructs and uses thereof||Dec 16, 2015||Application|